
Chinese pharmaceutical company established in August 2023 in Wuhan, Hubei with 27 million yuan of registered capital and close to 5,000 square metres of research and office space. Works on hospital preparations and traditional Chinese medicine research and contract manufacturing, medical consortium services and online sales, with a business scope covering medical research and experimental development, drug extraction, medicinal plant cultivation and medical device manufacture and sale.
평가 남기기